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ABSTRACT 
Objective:  The current study was conceived and performed to assess the pathophysiological, histological, and molecular manipulations of dextran 
sodium sulphate (DSS; MW: 5,000 Da) intervention in the rat and determined the changes in the antioxidant capacity of host and representative 
antioxidant enzymes. 
Methods: Wistar rats were fed with two different concentrations (3 and 5%) of DSS for seven days and caged for another seven days. Then colon 
and serum samples were collected, and colitis induction was assessed by histochemical examination. The level of antioxidant enzymes were 
determined by spectroscopy methods, and gene regulations were evaluated by qPCR. 
Results: The body mass of rat was gradually reduced to DSS intervention compared to naive control. The statistically significant level of reduction 
in the colon length has been recorded in DSS-treated rats (3% DSS-treated: 14.33±0.53 cm; 5% DSS-treated: 13.73±0.53 cm) compared to control 
(Control: 17.41±0.54 cm). The total histological scores of different study groups suggested that DSS causes the significant level of damages in rat 
colon. The antioxidant capacity of the host was significantly reduced in terms of trolox equivalence. About three-fold higher the amount of 
malondialdehyde was recorded in 5% DSS-treated group compared to control. The content of antioxidant enzymes were drastically reduced (1.4-
2.7 fold) upon DSS exposure than naïve control. The expression of selected inflammatory markers (IL-6, TNF-α, and iNOS) was up-regulated in DSS-
exposed groups. 
Conclusion: The current study clearly indicated that DSS altered the expression of selected inflammatory genes, antioxidant capacity, and 
scavenging enzymes in such a way that it facilitates the development of colitis in Wistar rat and the study provides the necessary information the 
experimental designing to explore the ability of any active principle against colitis using DSS (5 KDa) induced colitis rat model. 
Keywords: Dextran sodium sulphate, Colitis, Wistar rat, Antioxidant enzymes. 
 
INTRODUCTION 
The inflammatory bowel diseases (IBD), which include ulcerative 
colitis (UC) and Crohn’s disease (CD), are multifactorial diseases of 
unknown etiology [1]. The IBD is associated with colon cancer [2]. 
The use of the animal model, which with similar pathological, 
pathophysiological and histological features, for the study of IBD, 
has begun before three decades. Also, an animal model of IBD should 
have some desirable features like inflammatory mediator profile, 
response to treatment, predictable time of inflammation initiation 
and easy to induce IBD [3]. The most common way to cause the IBD 
in rat and mice is by the chemicals, 2, 4, 6-trinitrobenzene sulfonic 
acid (TNBS) and dextran sodium sulphate (DSS). TNBS and DSS were 
preferably used to induce CD, and UC conditions in laboratory 
animals, respectively and both the chemicals affect the intestinal 
barrier thereby they cause disease condition [4].  
Dextran is a glucose polymer produced by some bacterial species. 
DSS is the derivative of dextran with about 17% of sulphate and 
soluble in water. DSS is available with a vast range of molecular 
weight (MW) from 5,000 to 1.4 million Da [5]. Even though, 
oxazolone, acetic acid, nonsteroidal anti-inflammatory drugs 
(NSAIDs), carrageenan, and, peptidoglycan-polysaccharide (PGPS) 
are available for the induction of colitis in model organisms, DSS-
induced colitis model is more reliable, simple, cheap, and highly 
responsive [5, 6]. 
Previously, DSS with different MW were used at several 
concentration for colitis induction for example 4% of DSS (36,000-
44,000 Da), 5% of DSS (54,000 Da) for Wistar rats [7, 8], 4% of DSS 
(36,000-50,000 Da) for Sprague-Dawley rats [9], and 10% of DSS 
(5,00,000 Da) for BALB/c mice [10]. 
Previous studies demonstrated the pathophysiological and 
histological changes after induction of colitis by DSS of MW 5000 Da 
[11-15]. However, previous studies explained about consequences of 
DSS intervention, detailed information about changes in the 
antioxidant ability of the host is not yet available adequately. Thus, 
the current study was conceived and performed to assess the 
pathophysiological, histological, and molecular manipulations of DSS 
(MW: 5,000 Da) intervention in the rat. We also determined the 
changes in the antioxidant capacity of host and representative 
antioxidant enzymes. 
MATERIALS AND METHODS 
Strain and chemicals 
The Wistar rats were received from National Laboratory Animal 
Center, Mahidol University, Thailand for the study. The colitis-
inducing reagent, DSS (5,000 Da) was purchased from Wako Co., 
Ltd., Japan. The use of rat model and the experiments were 
conducted as per the regulation and approval of Ethical Committee 
of Faculty of Pharmacy, Chiang Mai University (Certificate of ethical 
clearance no. 01/2015). 
Groups and treatment 
Five-week-old male rats with an average weight of 170 g were 
maintained under a constant 12-h dark/light cycle at 25±1 °C 
(National Research Council of USA Guideline). They were randomly 
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divided into three groups as group 1(control; n = 6), group 2 (3% 
DSS exposure; n = 6), and group 3 (5% DSS exposure; n = 6). During 
the exposure period, respective rats were fed with 3 or 5% of DSS 
prepared in drinking water for seven days, and the control rats were 
fed with drinking water. All the rats were maintained for seven more 
days at ambient conditions and the weight of the animals were 
noted. Then, the rats were sacrificed (day 14) and collected the 
mucosal, and colon tissues for the evaluation of the impact of DSS. 
Sample preparation 
The proximal and distal parts of the colon were collected and fixed 
in 10% buffered formalin to study the pathological changes. About 
50 mg of colon tissue samples was collected and stored at-20 °C with 
500 µl of RNAzol® Regent until further process. The blood samples 
were collected and stored at 4 °C for serum level detection 
antioxidant capacity and enzymes. The colon length of the 
experimental rats was measured. 
Histological procedure 
The collected tissue samples were prepared for a paraffin block 
preparation by automatic tissue processor (model no. ATP 700 
Tissue processor, Hestion). The paraffin blocks of colonic tissues 
were sectioned serially at 5 µM thickness. After the sliced tissues 
had been fixed on clean glass slides, tissue samples were stained 
with hematoxylin and eosin (H&E). Pathological changes of colitis 
were defined as reported earlier [16] and scored as following. The 
loss of epithelium, loss of mucosal architecture, infiltration of 
mononuclear cells in lamina propria, infiltration of 
polymorphonuclear cells in lamina propria, and infiltration of 
inflammatory cells in submucosa were scored from 0-3 (0 = normal, 
1 = mild, 2 = moderate, 3 = severe). Whereas, abscess formation, 
erosion or ulceration, and goblet cell depletion were scored either 0 
or 1 (0 = absent, 1 = present). Pathological findings of colons after 
DSS exposure were presented as a sum of colitis score. 
Total antioxidant capacity and malondialdehyde determination 
The 2,2'-azino-bis-3-ethyl benzthiazoline-6-sulphonic acid (ABTS) 
assay was used for total antioxidant capacity (TAC) determination 
by the slightly modified procedure of Pengkumsri et al. [17]. About 
100 μL of serum samples were used and the results are represented 
as mg trolox equivalents of antioxidant capacity (TEAC)/ml of 
serum. The serum malondialdehyde (MDA) level was measured as 
reported [18]. All samples were tested in triplicate. 
Catalase, superoxide dismutase determination, and glutathione 
peroxidase activity 
The catalase, superoxide dismutase and glutathione peroxidase 
activities were measured in serum samples of the rat as reported by 
Yang et al. [19]. All experiments were carried out in triplicates, and 
the values were represented as U/ml. 
RNA isolation and qPCR 
The collected tissue samples were processed for RNA isolation as 
per the manufacturer’s instructions (RNAzol®, Sigma-Aldrich, 
Catalog no. R4533). The complementary DNA (cDNA) of the total 
RNA was prepared by following the manufacturer’s instructions 
(High Capacity cDNA Reverse Transcription kit, Applied 
biosystemsTM, Part no. 4368814). The expression of selected genes 
(IL-6 (FP: 5’-TCC TAC CCC AAC TTC CAA TGC TC-3’, RP: 5’-TTG GAT 
GGT CTT GGT CCT TAG CC-3’), TNFα (FP: 5’-AAA TGG GCT CCC TCT 
CAT CAG TTC-3’, RP: 5’-TCT GCT TGG TGG TTT GCT ACG AC-3’), iNOS 
(FP: 5’-CAT TGG AAG TGA AGC GTT TCG-3’, RP: 5’-CAG CTG GGC TGT 
ACA AAC CTT-3’) were evaluated by quantitative PCR with SYBR® 
green (Express SYBR® GreenERTM,Invitrogen) chemistry. The 
standard 30 cycles of polymerase reaction were performed in ABI 
7500® real-time PCR machine and analyzed by ABI 7500®software 
version 2.0.6. The fold changes (2-∆∆Ct) were calculated by 
normalizing the experimental control and internal control (β-actin; 
FP: 5’-ACA GGA TGC AGA AGG AGA TTA C-3’, RP: 5’-ACA GTG AGG 
CCA GGA TAG A-3’).  
Statistical analysis 
All the values are expressed as mean±SD. Analysis of variance 
(ANOVA) was used to test the difference in expression profile. The 
Least Significant Difference (LSD) post hoc test was performed in 
order to determine significant differences between groups (p<0.05) 
by the statistical SPSS software version 17. 
RESULTS AND DISCUSSION 
Physical impact of DSS exposure to rat 
As detailed, rats were fed with different concentration (3, 5%) of 
DSS for seven days, followed by animals were maintained for 
another seven days with regular diet. During the experimental 
period (14 d), the weight of the animals was recorded and found 




Fig. 1: A) Changes in the body mass of experimental rats. B) Impact of DSS treatment on colon length of rats (*** p<0.001) 
 
When compared to 3% of DSS intervention, 5% of DSS showed 
more impact on body mass of the experimental rats, whereas 
DSS-exposed rats are showed a reduction in weight compared to 
naive control (fig. 1A). The statistically significant level of 
reduction (Control: 17.41±0.54 cm; 3% DSS-treated: 14.33±0.53 
cm; 5% DSS-treated: 13.73±0.53 cm) in the colon length was also 
noted in both 3 and 5% DSS-treated rats compared to control 
(fig. 1B). Previous reports also revealed that DSS treatment 
reduces the colon size and body mass of the experimental animal 
[13, 20-22]. 
Histological changes 
The impact of DSS supplementation on colon tissues was assessed 
by histochemical studies. Both distal and proximal regions of the 
colon was examined with following parameters to measure the 
severity of the disease condition such as loss of epithelial, loss of 
mucosal architecture, mononuclear and polymorphonuclear cells in 
lamina propria, infiltration of inflammatory cells in submucosa, 
cryptitis and abscess formation, erosion or ulceration, and goblet 
cell depletion. 
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Table 1: Histological changes in colon after DSS exposure score are representative of mean values 
Pathological changes of colitis  Control Proximal part of colon Distal part of colon 
3% DSS 5% DSS 3% DSS 5% DSS 
Loss of epithelial 0 0 0 3 3 
Loss of mucosal architecture 0 0 0 3 3 
Mononuclear cells in lamina propria 0 1 1 2 2 
Polymorpho nuclear cells in lamina propria 0 0 0 3 3 
Infiltration of inflammatory cells in submucosa 0 0 0 3 3 
Cystitis and abscess formation 0 0 0 0 0 
Erosion or ulceration 0 0 0 1 1 
Goblet cell depletion 0 0 0 1 1 
Total score 0 1 1 14 14 
Note: The loss of epithelium, loss of mucosal architecture, infiltration of mononuclear cells in lamina propria, infiltration of polymorphonuclear cells 
in lamina propria, and infiltration of inflammatory cells in submucosa were scored from 0-3 (0 = normal, 1 = mild, 2 = moderate, 3 = severe). 
Whereas, abscess formation, erosion or ulceration, and goblet cell depletion were scored either 0 or 1 (0 = absent, 1 = present). 
 
We noticed that severe (score 3) epithelial loss, loss of integrity of 
mucosal architecture, polymorphonuclear cells in lamina propria, 
and infiltration of inflammatory cells in the submucosal region in the 
distal region of rat treated with DSS (both 3 and 5%). The moderate 
rate (score 2) of mononuclear cells in lamina propria, erosion or 
ulceration, and goblet cell depletion were also found at the distal 
region of the colon. Whereas, cystitis and abscess formation was not 
detected (fig.2, table.1). 
 
 
Fig. 2: Histological profile of a distal region of the DSS-treated and 
control rats observed with the aid of Hematoxylin and Eosin 
stain. EL: epithelial lining, C: crypts, GCD: globlet cell depletion, 
LP: lamina propria, IIC: infiltration of inflammatory cells E: 
erosion, MC: mucosa, SMC: submucosa, LGC: loss of globlet cells, 
SLEL: severe loss of epithelial lining, DC: dysplastic crypt 
 
In the proximal region, mild level (score 1) of mononuclear cells 
were observed in lamina propria, and other changes were not 
detected (fig. 3, Table. 1). The histological changes in the colon after 
DSS exposure has been reviewed extensively [15, 12]. The total 
histological scores of different study groups suggested that both 3 
and 5% DSS cause the relatively comparable level of severity in rats. 
Total antioxidant capacity and malondialdehyde determination 
DSS have been shown to cause the amplified production of free 
radicals [23]. The changes in the antioxidant capacity of the DSS-
treated rat were assessed by ABTS assay. The trolox equivalents of 
antioxidant capacity (TEAC) of DSS-exposed rats (3% DSS: 
0.49±0.03 mM; 5% DSS: 0.37±0.05 mM) were significantly reduced 




Fig. 3: Histological profile of proximal region of the DSS-treated 
and control rats observed with the aid of Hematoxylin and 
Eosin stain. EL: epithelial lining, C: crypts, GCD: globlet cell 
depletion, LP: lamina propria, IIIC: increase infiltration of 
inflammatory cells, MIIC: mild infiltration of inflammatory cells 
  
The reactive species provokes the damages to cell membranes by 
increasing the lipid peroxidation [24, 23]. Thus we studied the MDA 
level, known marker of lipid peroxidation, to detect the impact of 
DSS treatment on cell membrane integrity. As expected, the level of 
MDA was higher in both 3% (26.40±1.64 µM), and 5% (30.55±1.85 
µM) of DSS-treated rats compare to control (11.87±1.56 µM). About 
three-fold higher the amount of MDA was recorded in 5% DSS-
treated group (fig. 4B). 
Changes in antioxidant enzymes 
The changes in the level of representative antioxidant enzymes such 
as catalase (CAT), superoxide dismutase (SOD), and glutathione 
peroxidase (GPO) were determined in DSS-treated rats. In all cases 
significantly reduced the level of the antioxidant enzyme was 
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observed. The concentration of CAT, SOD, and GPO in 3% DSS-
treated groups were reduced from 220.30±11.23 U/ml, 94.52±8.54 
U/ml, and 233.74±13.27 U/ml to 92.72±10.03 U/ml, 55.36±9.35 
U/ml, and 190.76±12.75 U/ml, respectively. The higher dose of DSS 
(5%) causes a drastic reduction in the enzyme level compared to 
low dose (3%). About 2.7, 1.9, and 1.4 fold reduction in CAT, SOD, 
and GPO concentration was observed in 5% DSS-treated group 
compared to control, respectively (fig. 5). 
 
 
Fig. 4: A) Total antioxidant capacity of the host after DSS exposure. The values are represented as trolox equivalence (*** p<0.001). B) The 
rate of lipid peroxidation after DSS exposure and displayed as MDA values (*** p<0.001) 
 
 
Fig. 5: The profile of antioxidant enzymes such as catalase (A), superoxide dismutase (B), glutathione peroxidase (C) (* p<0.05; ** p<0.01; 
*** p<0.001) 
 
The reduction in the level of SOD and CAT has been reported in 
plasma samples of DSS-treated rats [25]. The current study also 
suggested that DSS affect the antioxidant system of host thereby it 
facilitates the diseased condition. 
Expression of inflammatory markers 
The representative inflammatory genes IL-6 (Interleukin-6), TNF-α 
(Tumor necrosis factor-α), and iNOS (inducible nitric oxide 
synthase) were selected as a marker for validating the inflammation 
in DSS-exposed rat model.  
 
 
Fig. 6: The expression pattern of selected inflammatory genes. 
The values were expressed as fold changes in DSS-treated 
group, and the values are normalized with control group and 
internal control gene (β-actin) (*** p<0.001) 
 
The results were expressed as fold changes in the respective mRNA 
with the normalization of control (naïve rat) and β -actin gene 
(internal control for qPCR). Significantly (p<0.001), elevated level of 
expression of IL-6, TNF-α, and iNOS was observed in DSS-treated 
rats in both low (3%) and high (5%) concentration groups, but 
slightly increased amount of mRNA was detected in 5% DSS-treated 
group than 3% DSS-treated group, except IL-6 (fig. 6). 
The inflammatory process and development of DSS-mediated colitis, 
acute to chronic, in mice, differs based on the genetic makeup of the 
strain [26]. It is previously known that during colitis condition the 
inflammatory genes were up regulated and a different set of 
inflammatory genes are there for the specific phase of DSS-induced 
colitis [15]. The current study clearly indicated that DSS altered the 
expression of selected inflammatory genes in such a way that it 
facilitates the development of colitis in wister rat. 
CONCLUSION 
The current study concrete the notion that DSS can cause a colitis-
like disease condition in a rat model. The concentration of DSS and 
its molecular mass also play the vital role in colitis induction. The 
antioxidant ability of the host, rate of lipid peroxidation and 
enzymes involved in free radical scavenging activity are disturbed 
by DSS. Moreover, this data will help to design the experiments for 
the study of the ability of any active principle against colitis using 
DSS (5 KDa) induced colitis rat model. 
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